Effects of K-115, a Rho-Kinase Inhibitor, on Aqueous Humor Dynamics in Rabbits

References

• Quigley HA. Open-angle glaucoma. N Engl J Med 1993;328:1097–1106
   PubMed Web of Science ®Google Scholar
• Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004;111:1641–1648
   PubMed Web of Science ®Google Scholar
• Shields MB. Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 2008;19:85–88
   PubMed Web of Science ®Google Scholar
• Bahrami H. Causal inference in primary open angle glaucoma: specific discussion on intraocular pressure. Ophthalmic Epidemiol 2006;13:283–289
   PubMed Web of Science ®Google Scholar
• Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446–456
   PubMed Web of Science ®Google Scholar
• Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005;33:891–895
   PubMed Web of Science ®Google Scholar
• Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997;389:990–994
   PubMed Web of Science ®Google Scholar
• Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol 2008;20:242–248
   PubMed Web of Science ®Google Scholar
• Rao VP, Epstein DL. Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma. Biodrugs 2007;21:167–177
   PubMed Web of Science ®Google Scholar
• Nakajima E, Nakajima T, Minagawa Y, Shearer TR, Azuma M. Contribution of ROCK in contraction of trabecular meshwork: proposed mechanism for regulating aqueous outflow in monkey and human eyes. J Pharm Sci 2005;94:701–708
   PubMed Web of Science ®Google Scholar
• Honjo M, Tanihara H, Inatani M, Kido N, Sawamura T, Yue BY, et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 2001;42:137–144
   PubMed Web of Science ®Google Scholar
• Waki M, Yoshida Y, Oka T, Azuma M. Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase. Curr Eye Res 2001;22:470–474
   PubMed Web of Science ®Google Scholar
• Honjo M, Inatani M, Kido N, Sawamura T, Yue BY, Honda Y, et al. Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes. Arch Ophthalmol 2001;119:1171–1178
   PubMed Web of Science ®Google Scholar
• Tamura M, Nakao H, Yoshizaki H, Shiratsuchi M, Shigyo H, Yamada H, et al. Development of specific Rho-kinase inhibitors and their clinical application. Biochimica et Biophysica Acta 2005;1754:245–252
   PubMed Web of Science ®Google Scholar
• Tokushige H, Inatani M, Nemoto S, Sakaki H, Katayama K, Uehata M, et al. Effects of topical administration of Y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest Ophthalmol Vis Sci 2007;48:3216–3222
   PubMed Web of Science ®Google Scholar
• Tanihara H, Abe H, Kuwayama Y, Yamamoto T, Araie M. Ocular hypotensive dose-response efficacy and safety of the rho kinase inhibitor, K-115, in patients with primary open-angle glaucoma and ocular hypertension. IOVS 2011;52:ARVO E-Abstract 220
   Google Scholar
• Yamamoto T, Abe H, Kuwayama Y, Tanihara H, Araie M. Efficacy and safety of the rho kinase inhibitor, K-115, over 24 hours in patients with primary open-angle glaucoma and ocular hypertension. IOVS. 2011;52:ARVO E-Abstract 216
   Google Scholar
• Kanno M, Araie M, Tomita K, Sawanobori K. Effects of topical Nipradilol, a, β-blocking agent with α-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation. Invest Ophthalmol Vis Sci 1998;39:736–743
   PubMedGoogle Scholar
• Suguro K, Toris CB, Pederson JE. Uveoscleral outflow following cyclodialysis in the monkey eye using a fluorescent tracer. Invest Ophthalmol Vis Sci 1985;26:810–813
   PubMed Web of Science ®Google Scholar
• Goh Y, Araie M, Nakajima M, Azuma I, Hayaishi O. Effect of topical prostaglandin D2 on the aqueous humor dynamics in rabbits. Graefes Arch Clin Exp Ophthalmol 1989;227:476–481
   PubMed Web of Science ®Google Scholar
• Mizuno K. Ocular hypotensive mechanism of α-, β-blocker (Nipradilol ophthalmic solution). Atarashii Ganka (J Eye) 1999;16:529–535. (in Japanese)
   Google Scholar
• Bárány EH. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure perfusion. Invest Ophthalmol Vis Sci 1964;3:135–143
   Google Scholar
• Taniguchi T, Okada K, Haque MS, Sugiyama K, Kitazawa Y. Effects of endothelin-1 on intraocular pressure and aqueous humor dynamics in the rabbit eye. Curr Eye Res 1994;13:461–464
   PubMed Web of Science ®Google Scholar
• Ono-Saito N, Niki I, Hidaka H. H-series protein kinase inhibitors and potential clinical applications. Pharmacol Ther 1999;82:123–131
   PubMed Web of Science ®Google Scholar
• Hidaka H, Kobayashi R. Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol 1992;32:377–397
   PubMed Web of Science ®Google Scholar
• Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Shibuya M, et al. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol 1989;98:1091–1100
   PubMed Web of Science ®Google Scholar
• Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984;23:5036–5041
   PubMed Web of Science ®Google Scholar
• Whitlock NA, Harrison B, Mixon T, Yu XQ, Wilson A, Gerhardt B, et al. Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK. J Ocul Pharmacol Ther 2009;25:187–194
   PubMed Web of Science ®Google Scholar
• Zamora DO, Kiel JW. Topical proparacaine and episcleral venous pressure in the rabbit. Invest Ophthalmol Vis Sci 2009;50:2949–2952
   PubMedGoogle Scholar
• Nishimura K, Kuwayama Y, Matsugi T, Sun N, Shirasawa E. Selective suppression by bunazosin of alpha-adrenergic agonist evoked elevation of intraocular pressure in sympathectomized rabbit eyes. Invest Ophthalmol Vis Sci 1993;34:1761–1766
   PubMed Web of Science ®Google Scholar
• Hosoya K, Lee VH, Kim KJ. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation. Eur J Pharm Biopharm 2005;60:227–240
   PubMed Web of Science ®Google Scholar
• Maurice DM, Mishima S. Ocular pharmacokinetics. In: Sears ML, editor. Pharmacology of the eye. Berlin: Springer-Verlag; 1984. pp 19–116
   Google Scholar
• Koga T, Koga T, Awai M, Tsutsui J, Yue BY, Tanihara H. Rho-associated protein kinase inhibitor, Y-27632, induces alterations in adhesion, contraction and motility in cultured human trabecular meshwork cells. Exp Eye Res 2006;82:362–370
   PubMed Web of Science ®Google Scholar